Akero Therapeutics (AKRO) Misses Q3 EPS by 1c

Akero Therapeutics (NASDAQ: AKRO) reported Q3 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
• SOL Strategies files amended Q2 fiscal 2026 interim financials